Patents Represented by Attorney Montgomery, McCracken, Walker & Rhoads, LLP
  • Patent number: 7741111
    Abstract: This invention relates generally to a novel CaM multi-functional protein kinase, which has been named Pregnancy Up-Regulated, Nonubiquitous CaM Kinase (PNCK), and to the nucleotide sequence encoding it. The kinase is temporally expressed during postnatal mammary development in a spatially heterogeneous manner in certain subsets of cells, and overexpressed in a subset of primary breast cancers. The invention further relates to an analysis of a correlation between carcinogenesis and postnatal development, particularly mammary development, especially associated with parity; as well as to methods of using the kinase, or gene encoding it, as markers, prognostic tools, screening tools and therapies, in vitro and in vivo that are based upon that correlation.
    Type: Grant
    Filed: March 13, 2006
    Date of Patent: June 22, 2010
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Lewis A. Chodosh, Heather P. Gardner
  • Patent number: 7727219
    Abstract: The present invention provides a method for expanding a pre-assembled closed, sterile container system used for the collection, transportation, storage and cryopreservation of biological fluids, such as, blood, bone marrow or umbilical cord blood. The closed sterile bag system comprises a plurality of parts including inlet and or outlet elements and regions for mixing and storing body fluids and cryopreservation liquids, wherein connecting lines provide sterile connection of each component, and wherein the parts are hermetically sealable and separable to maintain sterility system. The methods herein further provide a means for introducing fluids into and/or extracting fluids from a pre-assembled, closed, sterile container system, while maintaining a closed, sterile system without the need to operate under ultra-clean room conditions.
    Type: Grant
    Filed: May 26, 2004
    Date of Patent: June 1, 2010
    Assignee: Vita 34 AG
    Inventor: Eberhard F. Lampeter
  • Patent number: 7728159
    Abstract: The invention relates to new compounds of the formula, wherein R and R1 are each independently hydrogen, a linear or branched C1-40 alkyl, C2-40 alkenyl or C2-40 alkynyl group, an aryl or C1-40 alkylaryl group or an optionally complex metal ion Mn+/n wherein n is an integer from 1 to 8; the free valences of the silicate oxygen atoms are saturated by one or more of: silicon atoms of other groups of the formula, hydrogen, a linear or branched C1-12 alkyl group or by cross-linking bridge members R3qM1(OR2)mOk/2 or Al(OR2)3-pOp/2 or R3 Al(OR?)2-1 O1/2; wherein M1 is Si or Ti; R2 is linear or branched C1-12 alkyl group; and R3 is alinear or branched C1-6 alkyl group; k is an integer from 1 to 4 and q and m are integers from 0 to 2; such that M+k+q=4; and p is an integer from 1 to 3; and r is an integer from 1 to 2; or other known oxo metal bridging systems; x, y and z are integers such that the radio of x:y+z, varies from 0.
    Type: Grant
    Filed: June 19, 2006
    Date of Patent: June 1, 2010
    Assignee: Phosphonics Limited
    Inventors: Alice Caroline Sullivan, John Robert Howe Wilson
  • Patent number: 7705596
    Abstract: Methods of, and systems for, simultaneously compensating for external-magnetic-field inhomogeneity as well as radiofrequency magnetic-field inhomogeneity in an MRI system. In one method embodiment, a pulse sequence is applied when the transmitter-reference frequency is delivered on resonance. The pulse sequence includes radiofrequency pulses which may be applied at arbitrary-excitation-flip angles that are not necessarily 90° degrees. The pulse sequence also includes spin-locking pulses applied in concert with a refocusing-composite pulse. In another method embodiment, a pulse sequence is applied when the transmitter-reference frequency is delivered off resonance. This off-resonance-pulse sequence includes radiofrequency pulses which may be applied at arbitrary-excitation-flip angles that are not necessarily 90° degrees. Sandwiched between the excitation-flip angles are at least two off-resonance-spin-lock pulses applied at an inverse phase and frequency from each other.
    Type: Grant
    Filed: May 19, 2008
    Date of Patent: April 27, 2010
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Walter R. T. Witschey, Ari Borthakur, Mark A. Elliot, Ravinder Reddy
  • Patent number: 7653639
    Abstract: The invention comprises systems, methods and a computerized data management device for creating and using data relating to a medical or non-medical product or device to enhance the safety of the product or device. A vast amount of data regarding adverse events associated with a particular product or device is analyzed to identify new essential adverse events associated with the product or device. At least one database of new essential adverse event information is created and utilized, and new characteristics of or uses for the product or device related to the new essential adverse event information are determined. Adverse event information is gathered for a large number of population sub-groups. The system may also be programmed to incorporate the information into intellectual property and contract documents.
    Type: Grant
    Filed: May 15, 2006
    Date of Patent: January 26, 2010
    Assignee: Classen Immunotherapies, Inc.
    Inventor: John Barthelow Classen
  • Patent number: 7643664
    Abstract: The present invention comprises a system and method for analyzing trabecular bone structure. A means for scanning the trabecular bone using a magnetic resonance image (MRI) scanner generates bone image data, which is then processed including correcting, deshading and reducing noise in the image data.
    Type: Grant
    Filed: January 12, 2009
    Date of Patent: January 5, 2010
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Felix W. Wehrli, Bryon R Gomberg
  • Patent number: 7618584
    Abstract: The invention relates to a bag system for the cryopreservation of body fluids, that is blood, bone marrow or umbilical cord blood, the parts of the bag system being sterilized, and separable from one another, wherein liquids which permit and/or assist cryopreservation are located in the bag system and/or may be introduced into the bag system in a sterile form. The bag system, at least, comprising: a device for the direct removal of body fluid (1) from the living body, a region or number of regions for mixing the liquids with the body fluid and/or for storing the mixture of liquids and body fluid, a number of shut-off elements (2) and connecting lines (3) and an inlet element (4) and/or an outlet element (5).
    Type: Grant
    Filed: October 16, 2002
    Date of Patent: November 17, 2009
    Assignee: Vita 34 AG
    Inventors: Eberhard Lampeter, Dietmar Egger
  • Patent number: 7581350
    Abstract: A gardening apparatus that isolates a targeted plant for spraying of chemicals such as herbicides, while protecting desired vegetation in proximity to the targeted plant. The gardening apparatus can be held and operated in one hand, while the other hand is used to operate a sprayer. The apparatus includes an elongated shaft that permits a user to spray a targeted plant from a safe distance such as in an erect position. Located at the distal end of the shaft is a shield, and on the opposite proximal end of the shaft is a hand control mechanism for adjusting the opening and closing of the shield around a plant stem. The adjustability of the opening/closing of the shield through the hand control mechanism permits targeting of different sized stems as the shield can be adjustably configured to surround the stem, whether thick or thin, without having to touch the targeted plant by hand.
    Type: Grant
    Filed: September 26, 2006
    Date of Patent: September 1, 2009
    Assignee: RASCO, LLC
    Inventor: Richard M. Ram
  • Patent number: 7575890
    Abstract: Provided is a method and system for the rapid and accurate detection of growth and metabolism of a cellular microorganism in a population of microorganisms in a non-liquid, culture medium. Further provided is a gelled culture medium containing a non-toxic, water-soluble, phosphorescent compound which measures oxygen content (partial pressure) of an microorganism also contained therein, by oxygen-dependent quenching of phosphorescence; or the gel contains a fluorescent pH indicator that demonstrates growth of the microorganism by pH-dependent intensity change or wavelength shift in the emission spectrum. Further provided is a system and method for killing undesirable microorganisms or colonies in the culture medium without harming the surrounding microorganisms.
    Type: Grant
    Filed: January 18, 2006
    Date of Patent: August 18, 2009
    Assignee: Oxygen Enterprises, Ltd.
    Inventor: David F. Wilson
  • Patent number: 7502797
    Abstract: A client monitoring application operating on a client device records and monitors human activity performed thereon. The client monitoring application forwards recorded activity to supervisor server(s) over a network. The supervisor server(s) enable a human supervisor to review human activity performed on the client device, issue alerts to the human when a particular activity is performed on the client device, and/or instruct the client monitoring application to intercept and block certain activities or classes of activities from taking place on the client device at any time or at designated times, or limited to designated durations.
    Type: Grant
    Filed: October 15, 2004
    Date of Patent: March 10, 2009
    Assignee: Ascentive, LLC
    Inventors: Adam Schran, Michael J. Neil
  • Patent number: 7496980
    Abstract: An apparatus that transforms the surface of a commonly used operating table into a dedicated platform configured to support a patient in a prone position for back surgery or other medical procedures. In one embodiment, the apparatus includes a frame configured to rest on top of the surface of an operating table and support members attached to the frame, configured to support the patient in a prone position. Thus, the apparatus converts commonly used operating tables into a dedicated back surgery. The apparatus eliminates the use of various improvised support structures stuffed underneath the patient to provide support while on the operating table in a prone position.
    Type: Grant
    Filed: April 2, 2007
    Date of Patent: March 3, 2009
    Assignee: Patient Safety Transport Systems, LLC
    Inventor: Lewis Sharps
  • Patent number: 7488467
    Abstract: The present invention utilizes fluorescent lipids, particularly quenched phospholipid or cholesterol analogues, to facilitate screening for phenotypes representing perturbations of lipid processing; screening for genetic mutations that lead to disorders of phospholipid and/or cholesterol metabolism; and screening of compounds designed to treat disorders of phospholipid and/or cholesterol metabolism.
    Type: Grant
    Filed: January 13, 2003
    Date of Patent: February 10, 2009
    Assignees: Trustees of the University of Pennsylvania, Carnegie Institute of Washington
    Inventors: Steven Farber, Michael Pack, Marnie Halpern
  • Patent number: 7477770
    Abstract: The present indention comprises a system and method for analyzing trabecular bone structure. A means for scanning the trabecular bone using a magnetic resonance image (MRI) scanner generates bone image data, which is then processed including correcting, deshadi4 and reducing noise in the image data.
    Type: Grant
    Filed: December 5, 2002
    Date of Patent: January 13, 2009
    Assignee: The Trustees Of The University Of Pennsylvania
    Inventors: Felix W. Wehrli, Bryon R. Gomberg
  • Patent number: 7465723
    Abstract: The present invention relates to the use of carbamazepine derivatives in treating tinnitus.
    Type: Grant
    Filed: August 5, 2003
    Date of Patent: December 16, 2008
    Assignee: Novartis
    Inventor: Markus Schmutz
  • Patent number: 7451937
    Abstract: An innovative thermostat having a handicap access mode is described. When the handicap access mode is triggered, the thermostat accepts voice commands to control thermostat settings. This innovative thermostat is a particularly convenient feature for the visually impaired, and individuals with limited mobility. In one exemplary embodiment, the thermostat includes a controller operable in a direct input mode and/or a handicap access mode. When in the direct input mode, the controller receives user commands through mechanical actuation of an adjustment mechanism to adjust a thermostat setting. When in the handicap access mode the controller receives voice commands through a microphone to adjust a thermostat setting.
    Type: Grant
    Filed: July 13, 2005
    Date of Patent: November 18, 2008
    Assignee: Action Talkin Products, LLC
    Inventors: Scott W. Flood, Christopher G. Wanlass
  • Patent number: 7447595
    Abstract: Provided are means for evaluating and identifying putative substrates of the twin arginine translocation (Tat) secretory pathway in Streptomyces and other bacterial species. Also provided, therefore, are simple ways to express, secrete and purify correctly folded heterologous proteins on a large scale using host microorganisms, such as, Streptomyces and the Tat pathway therein. Many of the thus-produced proteins are of significant therapeutic value in the pharmaceutical and biochemical industries, particularly when they can be secreted from the host in fully-folded active form. Accordingly, there are further provided the heterologous proteins produced by the Tat secretion pathway using the foregoing methods, and the computer algorithm used to identify the Tat signal sequence and putative substrates.
    Type: Grant
    Filed: March 17, 2003
    Date of Patent: November 4, 2008
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Mechtild Pohlschroder, Jessica C Kissinger, R. Wesley Rose, Thomas Brueser, Kieran Dilks
  • Patent number: 7423141
    Abstract: Sequences in human preproendothelin-1 mRNA are described against which antisense oligonucleotides can be used to inhibit the synthesis of endothelin-1. This inhibition of endothelin-1 synthesis may be used to treat diseases where excess production of endothelin-1 is an underlying cause of the symptoms.
    Type: Grant
    Filed: November 18, 2002
    Date of Patent: September 9, 2008
    Assignee: William Harvey Research Ltd.
    Inventors: Roger Corder, Adrian P. L. Smith, Timothy W. Higgenbottam, Martine Rothblatt, John Vane, Delphine Dominique Marthe Lees
  • Patent number: D584546
    Type: Grant
    Filed: February 28, 2008
    Date of Patent: January 13, 2009
    Assignee: TBar, LLC
    Inventors: Susan Chu, Julia Rugg, Anthony Tsirantonakis
  • Jar
    Patent number: D612740
    Type: Grant
    Filed: January 7, 2009
    Date of Patent: March 30, 2010
    Inventor: Peter Leone
  • Patent number: D616993
    Type: Grant
    Filed: March 13, 2009
    Date of Patent: June 1, 2010
    Assignee: Novartis AG
    Inventors: Jan Muis, Lukas Fransen, Rutger Alexander Brest van Kempen, Alexander Adriaan Huntelerslag